Ghia P

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Visentin A, Gaffo E, Fürstenau M, ..., Trentin L, Bortoluzzi S

Leukemia 39 (12) 2957-2967 [2025-12-00; online 2025-09-19]

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Visentin A, Chatzikonstantinou T, Scarfò L, ..., Stamatopoulos K, Ghia P

Am. J. Hematol. 98 (12) 1856-1868 [2023-12-00; online 2023-09-29]

Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations.

Tausch E, Ljungström V, Agathangelidis A, ..., Rosenquist R, Stilgenbauer S

Blood 139 (22) 3340-3344 [2022-06-02; online 2022-04-05]

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Chatzikonstantinou T, Kapetanakis A, Scarfò L, ..., Stamatopoulos K, Ghia P

Leukemia 35 (12) 3444-3454 [2021-12-00; online 2021-11-01]

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Rosenquist R, Ghia P, Hadzidimitriou A, ..., Davi F, Stamatopoulos K

Leukemia 31 (7) 1477-1481 [2017-07-00; online 2017-04-25]